Cellular STAT3 Functions via PCBP2 To Restrain Epstein-Barr Virus Lytic Activation in B Lymphocytes

A major hurdle to killing Epstein-Barr virus (EBV)-infected tumor cells using oncolytic therapy is the presence of a substantial fraction of EBV-infected cells that does not support the lytic phase of EBV despite exposure to lytic cycle-promoting agents. To determine the mechanism(s) underlying this...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Virol
Autors principals: Koganti, Siva, Clark, Carissa, Zhi, Jizu, Li, Xiaofan, Chen, Emily I., Chakrabortty, Sharmistha, Hill, Erik R., Bhaduri-McIntosh, Sumita
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2015
Matèries:
Virus-Cell Interactions
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4403452/
https://ncbi.nlm.nih.gov/pubmed/25717101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00121-15
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars